This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Experts
David Reesman
Vice President, General Counsel
Contact
DavidReesman@westat.comOverview
David Reesman is Vice President, General Counsel, and Corporate Secretary and serves as Westat’s Ethics Program Compliance Officer. Reesman leads Westat’s legal function, which provides business-oriented solutions and oversight on corporate governance, employment, benefits, contracts, intellectual property, privacy, research integrity, risk management and litigation. His legal career spans over 30 years.
Education
- JD (with honors), University of Dayton School of Law
- BA, Criminology (with a minor in History), Indiana University of Pennsylvania
-
The Impact of ABAWD time limit reinstatement on SNAP participation and employment
Journal of Nutrition Education and Behavior
January 2023
Tracy Vericker, L. Wheaton, K. Baier, Joseph Gasper
DOILink for: The Impact of ABAWD time limit reinstatement on SNAP participation and employment -
Author response to e-cigarettes and respiratory disorder: The broader research context
Nicotine and Tobacco Research
January 2023
J.D. Sargent, K.C. Edwards, J. Emond, S. Tanski, Kristie Taylor, J.P. Pierce, M.L. Goniewicz, et al.
DOILink for: Author response to e-cigarettes and respiratory disorder: The broader research context -
Cardiovascular outcomes among combustible-tobacco and electronic nicotine delivery system (ENDS) users in Waves 1 through 5 of the Population Assessment of Tobacco and Health (PATH) Study, 2013-2019
19,
International Journal of Environmental Research and Public Health
January 2022
M.C. Mahoney, C. Rivard, H.L. Kimmel, H.T. Hammad, E. Sharma, M.J. Halenar, J. Sargent, et al.
DOILink for: Cardiovascular outcomes among combustible-tobacco and electronic nicotine delivery system (ENDS) users in Waves 1 through 5 of the Population Assessment of Tobacco and Health (PATH) Study, 2013-2019